Source:http://linkedlifedata.com/resource/pubmed/id/17663985
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-8-28
|
pubmed:abstractText |
To generate therapeutic T cells for adoptive immunotherapy, T cells specific to Epstein-Barr virus LMP2A were enriched on the basis of antigen-specific production of interferon-gamma (IFNgamma). The enriched T cells, contained over 60% LMP2A-specific effectors, were polyclonal and targeted multiple LMP2A epitopes. A high proportion of the enriched T cells produced the Th1 cytokines interleukin (IL)-2 and granulocyte monocyte colony stimulating factor, while few cells expressed the Th2 cytokines IL4 and IL10. The enriched T cells specifically lysed LMP2A-expressing target cells, with concomitant production of IFNgamma and surface expression of CD107, suggesting the involvement of the granule exocytosis-mediated cytolytic pathway. In addition, the enriched T cells expressed CD45RO, CD28 and CD27, but not CD45RA, consistent with a differentiation stage capable of self-renewal for long-term persistence. LMP2A-specific T cells enriched based on IFNgamma-production may provide improved efficacy for the treatment of Epstein-Barr virus related malignancy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD27,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD28,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD45,
http://linkedlifedata.com/resource/pubmed/chemical/EBV-associated membrane antigen...,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Matrix Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-8749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
246
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-91
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17663985-Antigens, CD27,
pubmed-meshheading:17663985-Antigens, CD28,
pubmed-meshheading:17663985-Antigens, CD45,
pubmed-meshheading:17663985-Cell Line, Tumor,
pubmed-meshheading:17663985-Epitopes,
pubmed-meshheading:17663985-Epstein-Barr Virus Infections,
pubmed-meshheading:17663985-Exocytosis,
pubmed-meshheading:17663985-Humans,
pubmed-meshheading:17663985-Immunotherapy, Adoptive,
pubmed-meshheading:17663985-Interferon-gamma,
pubmed-meshheading:17663985-Interleukins,
pubmed-meshheading:17663985-T-Lymphocytes,
pubmed-meshheading:17663985-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:17663985-Tumor Virus Infections,
pubmed-meshheading:17663985-Viral Matrix Proteins
|
pubmed:year |
2007
|
pubmed:articleTitle |
Interferon-gamma expressing EBV LMP2A-specific T cells for cellular immunotherapy.
|
pubmed:affiliation |
Division of Hematology/Oncology, Department of Pediatrics, Pennsylvania State College of Medicine, Pennsylvania State Milton S. Hershey Medical Center, Pennsylvania State Children's Hospital, 500 University Drive, Hershey, PA 17033-0850, USA. qsun@psu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|